BACKGROUND: We evaluated whether routine biannual sexually transmitted disease (STD) testing coupled with brief risk-reduction counseling reduces STD incidence and high-risk behaviors. METHODS: The SUN study is a prospective observational HIV cohort study conducted in 4 US cities. At enrollment and every 6 months thereafter, participants completed a behavioral survey and were screened for STDs, and if diagnosed, were treated. Medical providers conducted brief risk-reduction counseling with all patients. Among men who have sex with men (MSM), we examined trends in STD incidence and rates of self-reported risk behaviors before and after exposure to the risk-reduction intervention. The "preintervention" visit was the study visit that was at least 6 months after enrollment STD screening and treatment and at which the participant was first exposed to the intervention. The "postintervention" visit was 12 months later. RESULTS: Among 216 MSM with complete STD and behavioral data, median age was 44.5 years; 77% were non-Hispanic white; 83% were on highly active antiretroviral treatment; 84% had an HIV RNA level <400 copies/mL and the median CD4 (cluster of differentiation 4) count was 511 cells/mm. Twelve months after first exposure to the risk-reduction intervention, STD incidence declined from 8.8% to 4.2% (P = 0.041). Rates of unprotected receptive or insertive anal intercourse with HIV-positive partners increased (19% to 25%, P = 0.024), but did not change with HIV-negative partners or partners of unknown HIV status (24% to 22%, P = 0.590). CONCLUSIONS: STD incidence declined significantly among HIV-infected MSM after implementing frequent, routine STD testing coupled with risk-reduction counseling. These findings support adoption of routine STD screening and risk-reduction counseling for HIV-infected MSM.
BACKGROUND: We evaluated whether routine biannual sexually transmitted disease (STD) testing coupled with brief risk-reduction counseling reduces STD incidence and high-risk behaviors. METHODS: The SUN study is a prospective observational HIV cohort study conducted in 4 US cities. At enrollment and every 6 months thereafter, participants completed a behavioral survey and were screened for STDs, and if diagnosed, were treated. Medical providers conducted brief risk-reduction counseling with all patients. Among men who have sex with men (MSM), we examined trends in STD incidence and rates of self-reported risk behaviors before and after exposure to the risk-reduction intervention. The "preintervention" visit was the study visit that was at least 6 months after enrollment STD screening and treatment and at which the participant was first exposed to the intervention. The "postintervention" visit was 12 months later. RESULTS: Among 216 MSM with complete STD and behavioral data, median age was 44.5 years; 77% were non-Hispanic white; 83% were on highly active antiretroviral treatment; 84% had an HIV RNA level <400 copies/mL and the median CD4 (cluster of differentiation 4) count was 511 cells/mm. Twelve months after first exposure to the risk-reduction intervention, STD incidence declined from 8.8% to 4.2% (P = 0.041). Rates of unprotected receptive or insertive anal intercourse with HIV-positive partners increased (19% to 25%, P = 0.024), but did not change with HIV-negative partners or partners of unknown HIV status (24% to 22%, P = 0.590). CONCLUSIONS: STD incidence declined significantly among HIV-infected MSM after implementing frequent, routine STD testing coupled with risk-reduction counseling. These findings support adoption of routine STD screening and risk-reduction counseling for HIV-infected MSM.
Authors: Richard T Gray; Alexander Hoare; Garrett P Prestage; Basil Donovan; John M Kaldor; David P Wilson Journal: Sex Transm Dis Date: 2010-05 Impact factor: 2.830
Authors: Gary Marks; Gregorio A Millett; Trista Bingham; Jennifer Lauby; Christopher S Murrill; Ann Stueve Journal: Sex Transm Dis Date: 2010-05 Impact factor: 2.830
Authors: Karen W Hoover; Mary Butler; Kimberly Workowski; Felix Carpio; Stephen Follansbee; Beau Gratzer; Brad Hare; Barbara Johnston; John L Theodore; Michael Wohlfeiler; Guoyu Tao; John T Brooks; Terence Chorba; Kathleen Irwin; Charlotte K Kent Journal: Sex Transm Dis Date: 2010-12 Impact factor: 2.830
Authors: H M Truong; H-H M Truong; T Kellogg; J D Klausner; M H Katz; J Dilley; K Knapper; S Chen; R Prabhu; R M Grant; B Louie; W McFarland Journal: Sex Transm Infect Date: 2006-12 Impact factor: 3.519
Authors: Janet J Myers; Starley B Shade; Carol Dawson Rose; Kimberly Koester; Andre Maiorana; Faye E Malitz; Jennifer Bie; Mi-Suk Kang-Dufour; Stephen F Morin Journal: AIDS Behav Date: 2010-06
Authors: Nicole Crepaz; Gary Marks; Adrian Liau; Mary M Mullins; Latrina W Aupont; Khiya J Marshall; Elizabeth D Jacobs; Richard J Wolitski Journal: AIDS Date: 2009-08-24 Impact factor: 4.177
Authors: Tabor E Flickinger; Stephen Berry; P Todd Korthuis; Somnath Saha; M Barton Laws; Victoria Sharp; Richard D Moore; Mary Catherine Beach Journal: AIDS Patient Care STDS Date: 2013-06-26 Impact factor: 5.078
Authors: Christine L Mattson; Heather Bradley; Linda Beer; Christopher Johnson; William S Pearson; R Luke Shouse Journal: Clin Infect Dis Date: 2017-03-01 Impact factor: 9.079
Authors: Florian M E Wagenlehner; Norbert H Brockmeyer; Thomas Discher; Klaus Friese; Thomas A Wichelhaus Journal: Dtsch Arztebl Int Date: 2016-01-11 Impact factor: 5.594
Authors: Rob J Fredericksen; M Walcott; F M Yang; L E Gibbons; E Fitzsimmons; S Brown; K H Mayer; T C Edwards; S Loo; C Gutierrez; E Paez; L Dant; W C Mathews; M J Mugavero; D L Patrick; P K Crane; H M Crane Journal: J Gen Intern Med Date: 2018-09-24 Impact factor: 6.473